| Статус: | Recruiting |
| Фаза: | Phase 3 |
| Начало: | 7 июля 2021 г. |
| Окончание: | 29 декабря 2023 г. |
| Описание: | An Open Comprative Study of the Prophylactic Efficacy and a Non-comparative Study of the Immunogenicity and Safety of the Inactivated Whole-virion Concentrated Purified Coronavirus Vaccine (CoviVac), Produced by FSBSI "Chumakov Federal Scientific Center for Research and Development of Immune-and-Biological Products", on Volunteers at the Age of 18-60 Years |
| смотреть на ClinicalTrials.gov |
| Статус: | Completed |
| Фаза: | Phase 3 |
| Начало: | 22 февраля 2019 г. |
| Окончание: | 25 октября 2019 г. |
| Описание: | The first multicenter prospective, randomized, double-blind, placebo-controlled clinical trial of the pentavalent live vaccine for RVI prevention was conducted in Russia among healthy infants aged 2 months at the time of the first vaccination. |
| смотреть на ClinicalTrials.gov |
| Статус: | Completed |
| Фаза: | Phase 3 |
| Начало: | 25 июня 2018 г. |
| Окончание: | 27 июля 2018 г. |
| Описание: | The purpose of the presented study was to evaluate the safety and immunological efficacy in preventing the rotavirus infection within a cohort of healthy subjects (target age of 18-45 years old) by using the pentavalent rotavirus vaccine - Rota-V-Aid™ (live attenuated oral, freeze-dried). |
| смотреть на ClinicalTrials.gov |